This is the third clinical trial carried out with OMO-103, a drug developed at the Vall d’Hebron Institute of Oncology (VHIO), part of the Vall d’Hebron Campus at Barcelona, through the spin-off P...
Read more
Sycai Medical software characterizes lesions which enables early diagnosis and automates patient monitoring. For oncologic patients under treatment, it helps healthcare professionals to better underst...
Read more
The EphA4 protein, a key player in the organization of the visual system, performs unexpected functions as a 'cellular glue' during embryonic development.
Read more
Researchers at IDIBAPS- Hospital Clínic have developed and validated a new CAR-T therapy called ARI0003 at a preclinical level. The new therapy combines two therapeutic targets to boost effectiveness...
Read more
IDIBELL’s spin-off Aptadel Therapeutics develops RNA-based molecules to find alternative treatments against cancer that are more effective and less toxic than current ones.
Read more
Swanlaab Innvierte Agrifood-Tech has led a €2 million investment round in KOA Biotech, an innovative biotechnology company based in Barcelona that develops disruptive solutions for the aquaculture s...
Read more
Published in Cell Reports Medicine*, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation sequencing (NGS) for precise patient stratification and tr...
Read more
Aptadel Therapeutics, based in the Barcelona Science Park, receives support from the American Little Warrior Foundation with a financial injection of half a million dollars (480,000 euros) to strength...
Read more
The results of this trial will be crucial in understanding the molecular changes that may contribute to the development of benign and malignant breast lesions, and in the future, help to properly inte...
Read more
Researchers have successfully uncovered the molecular mechanisms by which bacterial cellulose patches stimulate the regeneration of plant wounds.
Read more
Using gene editing with CRISPR-Cas9, the team has been able to study these proteins without altering them or producing them in excess, thereby allowing observation of their true function.
Read more
It has benn described 25 new mouse models that recapitulate the main subtypes of hepatocellular carcinoma and allow personalised therapies to be tested. The potential of these models has been demonstr...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
